ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Formaldehyde Finding Criticized

March 7, 1986

Chest X-Rays In BRCA Carriers May Increase Cancer Risk

July 28, 2006

Funding Opportunities

September 13, 2002

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

July 23, 1993

ONF Seeks Applications For Grants In Fatigue

March 31, 1995